A large body of evidence confirmed that RECK modulated tumor cell proliferation, migration, and invasion via kins of signaling including p53 signaling, Notch 1 signaling, and Wnt/β-catenin pathways in cervical cancer, non-small cell lung cancer, and human mesenchymal stem cells [24–26]. This evidence concerns the gene NOTCH1 and cervical carcinoma.